SecBot SecBot
SECBOTREPLAY Home › Report › DNTH

DNTH · Three Dianthus Therapeutics executives, including the CEO and EVP of…

Dianthus Therapeutics, Inc. /DE/ · CLUSTER filed Mar 11, 2026 at 20:00 ET

At the news

BEARISHIMPACT 7/10

CLUSTER filed Mar 11, 2026 at 20:00 ET

Three Dianthus Therapeutics executives, including the CEO and EVP of R&D, exercised stock options and sold shares in the open market, collectively realizing over $7.5 million in proceeds. The sales represent a coordinated monetization of equity, with the CEO alone selling $3.5 million worth of stock.

  • CEO Garcia Marino sold 43,505 shares for $3.51 million after exercising options totaling 122,918 shares.
  • EVP Randhawa sold 33,830 shares for $2.76 million following option exercises.
  • Chief Accounting Officer Carr sold 15,852 shares for $1.28 million.
  • Total open-market sales by insiders: $7.53 million in one day.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access